Psoriasis of the face and flexures

Journal of Dermatological Treatment

Volumn 18, Issue 6, 2007, Pages 351-360

  Van De Kerkhof, Peter C M ^a   Murphy, Gillian M ^b   Austad, Joar ^c   Ljungberg, Anders ^d   Cambazard, Frederique ^e   Duvold, Laetitia Bouérat ^f  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BEAUMONT HOSPITAL   (Ireland)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^f LEO PHARMA A S   (Denmark)

Author keywords

Face; Facial; Flexural; Flexures; Psoriasis

Indexed keywords

BIFONAZOLE; CALCIPOTRIOL; CALCITRIOL; CHLOROXYLENOL; CLOBETASONE BUTYRATE; CORTICOSTEROID; DITHRANOL; EOSIN; ITRACONAZOLE; PIMECROLIMUS; TACALCITOL; TACROLIMUS; TAR; TAZAROTENE;

ATOPIC DERMATITIS; BURN; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFECT; DRUG SAFETY; FLUSHING; HUMAN; PATHOGENESIS; PHOTOTHERAPY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PRURITUS; PSORIASIS; PUVA; REVIEW; SIDE EFFECT; SKIN MANIFESTATION; TREATMENT OUTCOME;

ANTI-INFECTIVE AGENTS; CALCINEURIN; CHOLECALCIFEROL; DERMATOLOGIC AGENTS; EXTREMITIES; FACIAL DERMATOSES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PHOTOTHERAPY; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PSORIASIS;

EID: 36849091866     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630701341949     Document Type: Review

References (61)

1. Spuls Ph I. Clinical evidence for the treatment of moderate to severe psoriasis [Thesis]. Amsterdam: Academic Medical Centre; 2002.
2. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001;137:280-4.
3. Fauéré S, Adjadj L, Pawin H. How patients experience psoriasis: Results from a European survey. J Eur Acad Dermatol Venereol. 2005;19(suppl 3):2-6.
4. Dubertret L, Mrowietz U, Ranki A, van de Kerkhof PCM, Chimenti S, Lotti T, et al. On behalf of the EUROPSO patient survey. European patient perspectives on the impact of psoriasis: The EUROPSO patient membership survey. Br J Dermatol. 2006;155:729-36.
5. Van de Kerkhof PCM, de Hoop D, de Korte J, Cobelens SA, Kuipers MV. Patient compliance and disease management in the treatment of psoriasis in the Netherlands. Dermatology. 2000;200:292-9.
6. Farber EM, Bright RD, Nall ML. Psoriasis: A questionnaire survey of 2,144 patients. Arch Dermatol. 1968;98:248-59.
7. Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica. 1974;148:1-18.
8. Wang G, Li C, Gao T, Liu Y. Clinical analysis of 48 cases of inverse psoriasis: A hospital based study. Eur J Dermatol. 2005;15:176-8.
9. Nanda A, Kaut S, Kaur I, Kumar B. Childhood psoriasis: An epidemiological survey of 112 patients. Pediatr Dermatol. 1990;7:19-21.
10. Puissant A. Psoriasis in children under the age of ten: A study of 100 observations. Gazz Sanit. 1970;19:191-8.
11. Nyfors A, Lemholt K. Psoriasis in children: A short review and a survey of 245 patients. Br J Dermatol. 1975;92:437-48.
12. Yosipovitch G, Tang MBY. Practical management of psoriasis in the elderly: Epidemiology, clinical aspects, quality of life, patient education and treatment options. Drugs Aging. 2002;19:847-63.
13. Park JY, Kim JH, Choe YB. Facial psoriasis: Comparison of patients with and without facial involvement. J Am Acad Dermatol. 2004;50:582-4.
14. Bernhard JD, Person JR. Facial and eyelid psoriasis after cyclosporin withdrawal. Clin Exp Dermatol. 1991;16:401 [Letter].
15. Farber EM. Ear psoriasis. Cutis. 1992;50:105-7.
16. Erbagci I, Erbagci Z, Gungor K, Bekir N. Ocular anterior segment pathologies and tear film changes in patients with psoriasis vulgaris. Acta Med Okayama. 2003;57:299-303.
17. Karabulut AA, Yalvac IS, Vahaboglu H, Nurozler AB, Duman S. Conjunctival impression cytology and tear film changes in patients with psoriasis. Cornea. 1999;18:544-8.
18. Guin J. Eyelid dermatitis: Experience in 203 cases. J Am Acad Dermatol. 2002;47:755-65.
19. Rosenberg EW, Noah PW, Skinner RB, Vander Zwaag R, West SK, Browder JF. Microbial association of 167 patients with psoriasis. Acta Derm Venereol. 1989;69:72-5.
20. Flytstroem I, Bergbrant IM, Braared J, Brandberg LL. Microorganismes in intertriginous psoriasis: No evidence of candida. Acta Derm Venerol. 2003;83:121-3.
21. Peramiquel L, Puig L, Dalmau J, Ricart E, Roe E, Alomar A. Onset of flexural psoriasis during infliximab treatment for Crohn's disease. Clin Exp Dermatol. 2005;30:713-14.
22. Vissers WHPM, Roelofzen J, de Jong EM, van erp PE, van de kerkhof PCM. Flexural versus plaque lesions in psoriasis: An immunohistochemical differentiation. Eur J Dermatol. 2005;15:13-17.
23. Minsue Chen T, Cockerell CJ. Cutaneous manifestations of HIV infections and HIV-related disorders. In: Bolognia JL, Jorizzo JL, Rapini RP, editors. Dermatology. London: Mosby; 2003. p. 1199-216.
24. Verhagen AR, van der Wiel AG, Wuite GG. A typical psoriasis of the face and hands after psoralen plus UV-A treatment. Br J Dermatol. 1984;111:615-18.
25. Tegner E. Observations on PUVA treatment of psoriasis and on 5-s-cysteinyldopa after exposure to UV light. Acta Derm Venereol. 1983;107:1-68.
26. Tegner E. Seborrhoic dermatitis of the face induced by PUVA treatment. Acta Derm Venereol. 1983;63:335-9.
27. Lane CG, Craford GM. Psoriasis: A statistical study of 231 cases. Arch Dermatol. 1937;35:1051-61.
28. Braun-Falco O, Burg G, Farber EM. Psoriasis: Eine Fragebogenstudie bei 536 Patienten. Munch Med Wochenschr. 1972;114:1105-10.
29. Ros AM, Eklund G. Photosensitive psoriasis: an epidemiologic study. J Am Acad Dermatol. 1987;17:752-8.
30. Szabo E, Horkay I. Untersuchungen über die Lichtreaktionen bei Psoriasis-Patienten. Z Haut Geschlechtskr. 1965;39:425-9.
31. Ros AM, Wennersten G. Photosensitive psoriasis -clinical findings and phototest results. Photodermatol. 1986;3:317-26.
32. Kudoh K, Obata M, Torihuki W, Tagami H. Photosensitive psoriasis provoked by a suberythematous dose of ultraviolet B light. Dermatologica. 1988;176:138-42.
33. Millns JL, McDuffie FC, Muller SA, Jordan RE. Development of photosensitivity and a systemic lupus erythematosus-like syndrome in a patient with psoriasis. Arch Dermatol. 1978;114:1177-81.
34. Sahoo B, Kumar B. The coexistence of photosensitive psoriasis with chronic actinic dermatitis. Dermatology. 2002;204:77-9.
35. Thaci D, Paetzold S, Kaufmann R. Treatment of intertriginous and genito-anal psoriasis. Aktuell Dermatol. 2003;29:505-8.
36. Leigheb G, Gallus D, Spano G. Treatment with psoriasis with an antiseptic combination, in a double-blind comparison versus eosin. G Ital Dermatol Venereol. 2000;135:107-14.
37. Faergemann J. Treatment of sebopsoriasis with itraconazole. Mykoses. 1985;28:612-18.
38. Doering HF. Therapy and etiology of sebopsoriasis. Z Hautkr. 1985;6:1940-50.
39. Gupta AK, Bluhm R. Itraconazole for seborrhoic dermatitis. Skin Therapy Lett. 2002;7(suppl 1):4-8.
40. Heller G. Niedrig konzentriertes Dithranol bie Psoriasis des Gesichtes. Dermatol Monatsschr. 1989;175:35-9.
41. Lebwohl MG, Tan MH, Meador SL, Singer G. Limited application of fluticasone propionate ointment 0,005% in patients with psoriasis of the face and intertriginous areas. J Am Acad Dermatol. 2001;44:77-82.
42. Nakayama J. Four cases of sebopsoriasis or seborrheic dermatitis of the face and scalp successfully treated with 1α-24(R)-dihydroxycholecalciferol (tacalcitol) cream. Eur J Dermatol. 2000;10:528-32.
43. Tadaki T, Kato T, Tagami H. Topical active vitamin D-3 analogue, 1,24-dihydroxycholecalciferol, an effective new treatment for facial seborrhoeic dermatitis. J Dermatolog Treat. 1996;7:139-40.
44. Aste N. Tacalcitol ointment in the treatment of psoriasis. G Ital Dermatol Venereol. 2004;139:81-4.
45. Langer A, Stapor V, Verjans H, Elzerman J. Calcitriol ointment in the treatment of facial, hairline and retroauricular chronic plaque psoriasis. J Dermatolog Treat. 1996;7(suppl l):S15-S18.
46. Duweb GA, Eldebani S, Alhaddar J. Calcipotriol cream in the treatment of flexural psoriasis. Int J Tissue React. 2003;25:127-30.
47. Kienbaum S, Lehmann P, Ruzicka T. Topical calcipotriol in the treatment of intertriginous psoriasis. Br J Dermatol. 1996;135:647-50.
48. -1 ointment on chronic plaque psoriasis localized in facial, hairline, retroauriculair or flexural areas. Br J Dermatol. 2003;148:326-33.
49. Lebwohl M, Freeman AK, Chapman MS, Feldman SR, Hartle JE, Henning A. Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol. 2004;51:723-30.
50. Lebwohl M, Freeman A, Chapman MS, Feldman S, Hartle J, Henning A. Proven efficacy of tacrolimus for facial and intertriginous psoriasis. Arch Dermatol. 2005;141:1154 [Letter].
51. Gribetz C, Ling M, Lebwohl M, Pariser D, Draelos Z, Gottlieb AB, et al. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: A double-blind, randomized study. J Am Acad Dermatol. 2004;51:731-8.
52. Freeman AK, Linowski GJ, Brady C, Lind L, Vanveldhuisen P, Singer G, et al. Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas. J Am Acad Dermatol. 2003;48:564-8.
53. Yamamoto T, Nishioka K. Topical tacrolimus: An effective therapy for facial psoriasis. Eur J Dermatol. 2003;13:471-3.
54. Yamamoto T, Nishioka K. Topical tacrolimus is effective for facial lesions of psoriasis. Acta Dermatol Venereol. 2000;80:451 [Letter].
55. Kroft EMB, Erceg A, Maimets K, Vissers W, van der Valk PG, van de Kerkhof PCM. Tacrolimus ointment for the treatment of severe facial plaque psoriasis. J Eur Acad Dermatol Venereol. 2005;19:249-51.
56. Clayton TH, Harrison PV, Nicholls R, Delap M. Topical tacrolimus for facial psoriasis. Br J Dermatol. 2003;149:419-20.
57. Steele JA, Choi C, Kwong PC. Topical tacrolimus in the treatment of inverse psoriasis. J Am Acad Dermatol. 2005;53:713-16.
58. Kleyn CE, Woodcock D, Sharpe GR. The efficacy of 0.1% tacrolimus ointment compared with clobetasonebutyrate 0.05% ointment in patients with facial flexural or genital psoriasis. Br J Dermatol. 2005;153(suppl 1):33 [Abstract].
59. Rallis E, Nasiopoulou A, Kouskoukis C, Roussaki-Schulze A, Koumantaki E, Karpouzis A, et al. Successful treatment of genital and facial psoriasis with tacrolimus ointment 0.1%. Drugs Exp Clin Res. 2005;31:141-5.
60. Amichai B. Psoriasis of the glans penis in a child successfully treated with Elidel (pimecrolimus) cream. J Eur Acad Dermatol Venereol. 2004;18:742-3.
61. Gollnick HPM, Finzi AF, Marks R, Barker JN, Jansen C, Revuz J, et al. Optimizing the use of tazarotene in clinical practice: Consensus statement from the European Advisory Panel for tazarotene (Zorac™). Dermatology. 1999;199:40-6.